Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Paris

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Brain Research|January 30, 2004
Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic miceDaniel Paris, Amita Quadros, James Humphrey, et al.
Bioorganic Chemistry|February 27, 2021
Novel, natural allosteric inhibitors and enhancers of Candida rugosa lipase activityAriane Menden, Stefan Crynen, Venkatarian Mathura, et al.
The Journal of Biological Chemistry|July 21, 2019
Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation <i>in vitro</i> and <i>in vivo</i>Jonas Elias Schweig, Hailan Yao, Kyle Coppola, et al.
Neuroscience Letters|January 16, 2007
Inhibition of Abeta production by NF-kappaB inhibitorsDaniel Paris, Nikunj Patel, Amita Quadros, et al.
Ticks and Tick-Borne Diseases|July 21, 2018
Isolation of a divergent strain of Rickettsia japonica from Dew's Australian bat Argasid ticks (Argas (Carios) dewae) in Victoria, AustraliaLeonard Izzard, Matthew Chung, Julie Dunning Hotopp, et al.
Bioinformation|July 9, 2011
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanismDaniel Paris, Venkat Mathura, Ghania Ait-Ghezala, et al.
Plos One|May 27, 2015
Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADMegha Verma, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, et al.
Journal of Neurotrauma|November 29, 2016
Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain InjuryScott Ferguson, Benoit Mouzon, Daniel Paris, et al.
Scientific Reports|April 13, 2021
A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau miceAlexander Morin, Benoit Mouzon, Scott Ferguson, et al.
Brain Research. Molecular Brain Research|May 17, 2005
Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cellsDaniel Paris, Ghania Ait-Ghezala, Venkatarajan S Mathura, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Brain Research|January 30, 2004
Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic miceDaniel Paris, Amita Quadros, James Humphrey, et al.
Bioorganic Chemistry|February 27, 2021
Novel, natural allosteric inhibitors and enhancers of Candida rugosa lipase activityAriane Menden, Stefan Crynen, Venkatarian Mathura, et al.
The Journal of Biological Chemistry|July 21, 2019
Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation <i>in vitro</i> and <i>in vivo</i>Jonas Elias Schweig, Hailan Yao, Kyle Coppola, et al.
Neuroscience Letters|January 16, 2007
Inhibition of Abeta production by NF-kappaB inhibitorsDaniel Paris, Nikunj Patel, Amita Quadros, et al.
Ticks and Tick-Borne Diseases|July 21, 2018
Isolation of a divergent strain of Rickettsia japonica from Dew's Australian bat Argasid ticks (Argas (Carios) dewae) in Victoria, AustraliaLeonard Izzard, Matthew Chung, Julie Dunning Hotopp, et al.
Bioinformation|July 9, 2011
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanismDaniel Paris, Venkat Mathura, Ghania Ait-Ghezala, et al.
Plos One|May 27, 2015
Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADMegha Verma, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, et al.
Journal of Neurotrauma|November 29, 2016
Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain InjuryScott Ferguson, Benoit Mouzon, Daniel Paris, et al.
Scientific Reports|April 13, 2021
A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau miceAlexander Morin, Benoit Mouzon, Scott Ferguson, et al.
Brain Research. Molecular Brain Research|May 17, 2005
Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cellsDaniel Paris, Ghania Ait-Ghezala, Venkatarajan S Mathura, et al.
Pageof 9